Table:
begin	end	state
1	27	signal peptide
28	35	non-cytoplasmic
36	53	transmembrane
54	58	cytoplasmic
59	75	transmembrane
76	80	non-cytoplasmic
81	101	transmembrane
102	107	cytoplasmic
108	129	transmembrane
130	140	non-cytoplasmic
141	161	transmembrane
162	167	cytoplasmic
168	186	transmembrane
187	218	non-cytoplasmic
219	239	transmembrane
240	257	cytoplasmic
258	280	transmembrane
281	290	non-cytoplasmic
291	309	transmembrane
310	316	cytoplasmic
317	338	transmembrane
339	349	non-cytoplasmic
350	379	transmembrane
380	481	cytoplasmic

Input:
>AO353_23030 FitnessBrowser__pseudo3_N2E3:AO353_23030
MKSKRLRADALAGLTTSFALLPECIAFALVAHLNPLMGLYGAFIICTLTALFGGRPGMIS
GAAGSMAVVIVALVVQHGVQYLLATVLMGGLLMMAFGLLRLGKLVRMVPYPVMLGFVNGL
AIVIALAQLEHFKSGGTWLSGTALYLMIGLVALTMAIVYVLPRLTRAVPPALVAILGVGL
AVYLLGLPTRTLGDMAHIAGGLPGLALPQVPWNLETLRIVAPYAVLMALVGLLETLLTLN
LTDEITESRGYPDRECVALGAANMVSGLFGGMGGCAMIGQTVINLSSSGRGRLSGVVAGV
MILLFILFLSPQIERIPLAALVGVMFVVAQQTFAWASLRVLNKVPLNDVLVIIAVTIITV
FTDLAIAVLCGIVIAALNFAWQQARELYADSYLEADGSKLYRLHGTLFFASTAPFLNQFD
PANDPPQVTLDCRHLSFVDYSAVAALKTLRERYVKTGKQLRVYHLSERCKKMLKRAGVDH
D

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server